Literature DB >> 33458322

Delivered dose quantification in prostate radiotherapy using online 3D cine imaging and treatment log files on a combined 1.5T magnetic resonance imaging and linear accelerator system.

Charis Kontaxis1, Daan M de Muinck Keizer1, Linda G W Kerkmeijer1, Thomas Willigenburg1, Mariska D den Hartogh1, Jochem R N van der Voort van Zyp1, Eline N de Groot-van Breugel1, Jochem Hes1, Bas W Raaymakers1, Jan J W Lagendijk1, Hans C J de Boer1.   

Abstract

BACKGROUND AND
PURPOSE: Monitoring the intrafraction motion and its impact on the planned dose distribution is of crucial importance in radiotherapy. In this work we quantify the delivered dose for the first prostate patients treated on a combined 1.5T Magnetic Resonance Imaging (MRI) and linear accelerator system in our clinic based on online 3D cine-MR and treatment log files.
MATERIALS AND METHODS: A prostate intrafraction motion trace was obtained with a soft-tissue based rigid registration method with six degrees of freedom from 3D cine-MR dynamics with a temporal resolution of 8.5-16.9 s. For each fraction, all dynamics were also registered to the daily MR image used during the online treatment planning, enabling the mapping to this reference point. Moreover, each fraction's treatment log file was used to extract the timestamped machine parameters during delivery and assign it to the appropriate dynamic volume. These partial plans to dynamic volume combinations were calculated and summed to yield the delivered fraction dose. The planned and delivered dose distributions were compared among all patients for a total of 100 fractions.
RESULTS: The clinical target volume underwent on average a decrease of 2.2% ± 2.9% in terms of D99% coverage while bladder V62Gy was increased by 1.6% ± 2.3% and rectum V62Gy decreased by 0.2% ± 2.2%.
CONCLUSIONS: The first MR-linac dose reconstruction results based on prostate tracking from intrafraction 3D cine-MR and treatment log files are presented. Such a pipeline is essential for online adaptation especially as we progress to MRI-guided extremely hypofractionated treatments.
© 2020 The Authors.

Entities:  

Keywords:  Dose accumulation pipeline; Intrafraction cine-MR; MR-linac; Prostate cancer; Soft-tissue motion tracking; Treatment log files

Year:  2020        PMID: 33458322      PMCID: PMC7807644          DOI: 10.1016/j.phro.2020.06.005

Source DB:  PubMed          Journal:  Phys Imaging Radiat Oncol        ISSN: 2405-6316


  19 in total

1.  Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.

Authors:  Anders Widmark; Adalsteinn Gunnlaugsson; Lars Beckman; Camilla Thellenberg-Karlsson; Morten Hoyer; Magnus Lagerlund; Jon Kindblom; Claes Ginman; Bengt Johansson; Kirsten Björnlinger; Mihajl Seke; Måns Agrup; Per Fransson; Björn Tavelin; David Norman; Björn Zackrisson; Harald Anderson; Elisabeth Kjellén; Lars Franzén; Per Nilsson
Journal:  Lancet       Date:  2019-06-18       Impact factor: 79.321

2.  Magnetic Resonance Imaging-Guided Radiation Therapy: A Short Strengths, Weaknesses, Opportunities, and Threats Analysis.

Authors:  Marcel van Herk; Alan McWilliam; Michael Dubec; Corinne Faivre-Finn; Ananya Choudhury
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-08-01       Impact factor: 7.038

3.  Soft-tissue prostate intrafraction motion tracking in 3D cine-MR for MR-guided radiotherapy.

Authors:  D M de Muinck Keizer; L G W Kerkmeijer; M Maspero; A Andreychenko; J R N van der Voort van Zyp; C A T van den Berg; B W Raaymakers; J J W Lagendijk; J C J de Boer
Journal:  Phys Med Biol       Date:  2019-12-05       Impact factor: 3.609

4.  Dosimetric impact of soft-tissue based intrafraction motion from 3D cine-MR in prostate SBRT.

Authors:  D M de Muinck Keizer; C Kontaxis; L G W Kerkmeijer; J R N van der Voort van Zyp; C A T van den Berg; B W Raaymakers; J J W Lagendijk; J C J de Boer
Journal:  Phys Med Biol       Date:  2020-01-17       Impact factor: 3.609

5.  Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.

Authors:  Scott C Morgan; Karen Hoffman; D Andrew Loblaw; Mark K Buyyounouski; Caroline Patton; Daniel Barocas; Soren Bentzen; Michael Chang; Jason Efstathiou; Patrick Greany; Per Halvorsen; Bridget F Koontz; Colleen Lawton; C Marc Leyrer; Daniel Lin; Michael Ray; Howard Sandler
Journal:  Pract Radiat Oncol       Date:  2018-10-11

6.  Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer.

Authors:  Twyla R Willoughby; Patrick A Kupelian; Jean Pouliot; Katsuto Shinohara; Michelle Aubin; Mack Roach; Lisa L Skrumeda; James M Balter; Dale W Litzenberg; Scott W Hadley; John T Wei; Howard M Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-01       Impact factor: 7.038

7.  The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans.

Authors:  Katja M Langen; Bhavin Chauhan; Jeffrey V Siebers; Joseph Moore; Patrick A Kupelian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-06       Impact factor: 7.038

8.  Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI).

Authors:  Michel J Ghilezan; David A Jaffray; Jeffrey H Siewerdsen; Marcel Van Herk; Anil Shetty; Michael B Sharpe; Syed Zafar Jafri; Frank A Vicini; Richard C Matter; Donald S Brabbins; Alvaro A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

9.  Application of the No Action Level (NAL) protocol to correct for prostate motion based on electronic portal imaging of implanted markers.

Authors:  Hans C J de Boer; Marjolein J H van Os; Peter P Jansen; Ben J M Heijmen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-15       Impact factor: 7.038

10.  Dosimetric consequences of intrafraction prostate motion.

Authors:  Haisen S Li; Indrin J Chetty; Charles A Enke; Ryan D Foster; Twyla R Willoughby; Patrick A Kupellian; Timothy D Solberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-30       Impact factor: 7.038

View more
  12 in total

1.  Assessment of intrafractional prostate motion and its dosimetric impact in MRI-guided online adaptive radiotherapy with gating.

Authors:  Yuqing Xiong; Moritz Rabe; Lukas Nierer; Maria Kawula; Stefanie Corradini; Claus Belka; Marco Riboldi; Guillaume Landry; Christopher Kurz
Journal:  Strahlenther Onkol       Date:  2022-09-23       Impact factor: 4.033

2.  Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.

Authors:  Anita M Werensteijn-Honingh; Petra S Kroon; Dennis Winkel; J Carlijn van Gaal; Jochem Hes; Louk M W Snoeren; Jaleesa K Timmer; Christiaan C P Mout; Gijsbert H Bol; Alexis N Kotte; Wietse S C Eppinga; Martijn Intven; Bas W Raaymakers; Ina M Jürgenliemk-Schulz
Journal:  Phys Imaging Radiat Oncol       Date:  2022-06-30

3.  On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy.

Authors:  Daan M de Muinck Keizer; Jochem R N van der Voort van Zyp; Eline N de Groot-van Breugel; Bas W Raaymakers; Jan J W Lagendijk; Hans C J de Boer
Journal:  Phys Imaging Radiat Oncol       Date:  2021-07-25

4.  Fast and accurate deformable contour propagation for intra-fraction adaptive magnetic resonance-guided prostate radiotherapy.

Authors:  Thomas Willigenburg; Cornel Zachiu; Jan J W Lagendijk; Jochem R N van der Voort van Zyp; Hans C J de Boer; Bas W Raaymakers
Journal:  Phys Imaging Radiat Oncol       Date:  2022-02-17

5.  Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prostate cancer.

Authors:  Subaru Sawayanagi; Hideomi Yamashita; Mami Ogita; Ryosuke Takenaka; Yuki Nozawa; Yuichi Watanabe; Toshikazu Imae; Osamu Abe
Journal:  Radiat Oncol       Date:  2022-02-23       Impact factor: 3.481

Review 6.  MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers.

Authors:  Samuel L Mulder; Jolien Heukelom; Brigid A McDonald; Lisanne Van Dijk; Kareem A Wahid; Keith Sanders; Travis C Salzillo; Mehdi Hemmati; Andrew Schaefer; Clifton D Fuller
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.575

7.  Experimental investigation of dynamic real-time rotation-including dose reconstruction during prostate tracking radiotherapy.

Authors:  Casper Gammelmark Muurholm; Thomas Ravkilde; Robin De Roover; Simon Skouboe; Rune Hansen; Wouter Crijns; Tom Depuydt; Per R Poulsen
Journal:  Med Phys       Date:  2022-04-25       Impact factor: 4.506

8.  Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac.

Authors:  Jennifer Dang; Vickie Kong; Winnie Li; Inmaculada Navarro; Jeff D Winter; Victor Malkov; Alejandro Berlin; Charles Catton; Jerusha Padayachee; Srinivas Raman; Padraig Warde; Peter Chung
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2022-08-27

9.  Daily online contouring and re-planning versus translation-only correction in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.

Authors:  Frederik R Teunissen; Jochem R N van der Voort van Zyp; Eline N de Groot-van Breugel; Helena M Verkooijen; Ruud C Wortel; Johannes C J de Boer
Journal:  Phys Imaging Radiat Oncol       Date:  2022-09-13

Review 10.  [Primary treatment of prostate cancer using 1.5 T MR-linear accelerator].

Authors:  Daniel Wegener; Daniel Zips; Cihan Gani; Simon Boeke; Konstantin Nikolaou; Ahmed E Othman; Haidara Almansour; Frank Paulsen; Arndt-Christian Müller
Journal:  Radiologe       Date:  2021-07-23       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.